These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 641391)

  • 1. Hemoperfusion removal of digoxin from dogs.
    Gibson TP; Lucas SV; Nelson HA; Atkinson AJ; Okita GT; Ivanovich P
    J Lab Clin Med; 1978 Apr; 91(4):673-82. PubMed ID: 641391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin removal from an anephric patient by hemoperfusion over XAD-4.
    Gibson TP; Nelson HA; Ivanovich P
    Artif Organs; 1978 Nov; 2(4):398-401. PubMed ID: 743014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of digitalis intoxication by charcoal hemoperfusion (CHP).
    Carvallo A; Ramirez B; Honig H; Knepshield J; Schreiner GE; Gelfand MC
    Trans Am Soc Artif Intern Organs; 1976; 22():718-22. PubMed ID: 951891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin removal from a patient with renal failure by hemoperfusion with Amberlite XAD-4 resin.
    Hoy W; Gibson TP; Biddle T
    Artif Organs; 1979 May; 3(2):124-6. PubMed ID: 533394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of XAD-4 and charcoal hemoperfusion for removal of digoxin and digitoxin.
    Gibson TP
    Kidney Int Suppl; 1980 Sep; 10():S101-5. PubMed ID: 6934330
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of the experimental chronic digitalisintoxication by hemoperfusion (author's transl)].
    Bischoff KO; Flohr E; Graben N; Hager W; Merguet P
    Z Kardiol; 1977 Nov; 66(11):656-62. PubMed ID: 595775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is hemoperfusion effective in the treatment of digoxin intoxication? (author's transl)].
    Risler T; Arnold G; Grabensee B
    Z Kardiol; 1979 May; 68(5):313-9. PubMed ID: 463188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute intoxication with diisopyramide: clinical and experimental study by hemoperfusion an Amberlite XAD 4 resin.
    Gosselin B; Mathieu D; Chopin C; Wattel F; Dupuis B; Haguenoer JM; Desprez M
    Clin Toxicol; 1980 Oct; 17(3):439-49. PubMed ID: 7449357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin acute intoxication: evaluation of the efficiency of charcoal hemoperfusion.
    Clerckx-Braun F; Kadima N; Lesne M; Mahieu P; Vandenbroucke JM
    Clin Toxicol; 1979; 15(4):437-46. PubMed ID: 540492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resin hemoperfusion in dogs intoxicated with ethychlorvynol (Placidyl).
    Zmuda MJ
    Kidney Int; 1980 Mar; 17(3):303-11. PubMed ID: 7401450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Artificial liver support system: removal of bilirubin and bile acids by hemoperfusion with ionex-column].
    Hamaguchi M
    Nihon Geka Gakkai Zasshi; 1983 Jan; 84(1):63-73. PubMed ID: 6674764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of digoxin in the cat and comparisons with man and the dog.
    Weidler DJ; Jallad NS; Movahhed HS; Sakmar E; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):57-66. PubMed ID: 625594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renal clearance of digoxin is dependent upon the serum digoxin concentration.
    Gibson TP; Quintanilla AP
    J Pharmacol Exp Ther; 1980 Dec; 215(3):681-4. PubMed ID: 7441526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive digitoxin intoxication. Treatment of Amberlite XAD 4 resin hemoperfusion.
    Mathieu D; Gosselin B; Nolf M; Dupuis B; Marchandise X; Boidein M; Wattel F
    J Toxicol Clin Toxicol; 1982 Nov; 19(9):931-50. PubMed ID: 7182522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability of acyclovir in the dog.
    Krasny HC; de Miranda P; Blum MR; Elion GB
    J Pharmacol Exp Ther; 1981 Feb; 216(2):281-8. PubMed ID: 7463350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of spironolactone on the renal clearance of digoxin in dogs.
    O'Brien MS; Salamone LF; Gibson TP
    J Pharmacol Exp Ther; 1985 Jul; 234(1):190-4. PubMed ID: 4009501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilirubin and bile acids removal by haemoperfusion through synthetic resin "Persorb".
    Filip K; Malý J; Horký J; Tlustáková M; Kálal J; Vrána M
    Czech Med; 1990; 13(1):34-7. PubMed ID: 2350992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of bretylium in dogs and the effect of hemoperfusion on elimination.
    Kamath BL; Gibson TP; Look ZM; McEntegart CM; Comrie EB; Yacobi A
    J Pharm Sci; 1982 Nov; 71(11):1294-6. PubMed ID: 7175729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum digoxin concentrations in dogs before, during, and after concomitant treatment with phenobarbital.
    Pedersoli WM; Ganjam VK; Nachreiner RF
    Am J Vet Res; 1980 Oct; 41(10):1639-42. PubMed ID: 7224289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin disposition kinetics in dogs before and during azotemia.
    Gierke KD; Perrier D; Mayersohn M; Marcus FI
    J Pharmacol Exp Ther; 1978 May; 205(2):459-64. PubMed ID: 641840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.